Cargando…
SLC1A3 promotes gastric cancer progression via the PI3K/AKT signalling pathway
Gastric cancer is a major cause of mortality worldwide. The glutamate/aspartate transporter SLC1A3 has been implicated in tumour metabolism and progression, but the roles of SLC1A3 in gastric cancer remain unclear. We used bioinformatics approaches to analyse the expression of SLC1A3 and its role in...
Autores principales: | Xu, Liyi, Chen, Jiamin, Jia, Litao, Chen, Xiao, Awaleh Moumin, Faycal, Cai, Jianting |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7753768/ https://www.ncbi.nlm.nih.gov/pubmed/33145952 http://dx.doi.org/10.1111/jcmm.16060 |
Ejemplares similares
-
Gastric Xanthoma Associated with Gastric Cancer Development: An Updated Review
por: Moumin, Faycal Awaleh, et al.
Publicado: (2020) -
SLC25A32 promotes malignant progression of glioblastoma by activating PI3K-AKT signaling pathway
por: Xue, Zhiwei, et al.
Publicado: (2023) -
LGR6 promotes the progression of gastric cancer through PI3K/AKT/mTOR pathway
por: Ke, Jing, et al.
Publicado: (2018) -
Progression of the PI3K/Akt signaling pathway in chronic obstructive pulmonary disease
por: Liu, Yanhui, et al.
Publicado: (2023) -
YARS as an oncogenic protein that promotes gastric cancer progression through activating PI3K-Akt signaling
por: Zhang, Cheng, et al.
Publicado: (2020)